University of Calif Irvine Med Cntr — Irvine, California

University of Calif Irvine Med Cntr is a clinical research site located in Irvine, California, United States 92660.

Crixeo Clinical Trials Trust Score: 93/100 (GOOD). This profile has not yet been claimed by the site owner.

University of Calif Irvine Med Cntr has participated in 7 clinical trials with 4 currently active.

Therapeutic areas: Cardiovascular Disease and Lipoprotein(a), Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease.

Sponsors: Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Irvine

Browse all research sites in California · View every site in Irvine

Sponsor Feasibility Report

Trust Score: 93/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of Calif Irvine Med Cntr?

University of Calif Irvine Med Cntr has a Crixeo Trust Score of 93/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of Calif Irvine Med Cntr conducted?

University of Calif Irvine Med Cntr has 7 clinical trials on record, with 4 currently active. Their work covers Cardiovascular Disease and Lipoprotein(a), Elevated Lp(a) and Established Atherosclerotic Cardiovascular Disease, Atherosclerotic Cardiovascular Disease.

Is University of Calif Irvine Med Cntr accredited by Crixeo Clinical Trials?

University of Calif Irvine Med Cntr has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of Calif Irvine Med Cntr?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.